Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04173507
Title Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.